MILLENNIUM MANAGEMENT LLC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 104 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$10,518,820
+124.5%
605,574
+82.0%
0.01%
+150.0%
Q2 2023$4,685,064
+69432.0%
332,746
-46.9%
0.00%
-50.0%
Q1 2023$6,738
-41.6%
626,198
-18.7%
0.00%
-33.3%
Q4 2022$11,544
-99.9%
770,650
-18.3%
0.01%
-14.3%
Q3 2022$12,111,000
+378.1%
943,199
+260.9%
0.01%
+250.0%
Q2 2022$2,533,000
-74.2%
261,372
-73.6%
0.00%
-60.0%
Q1 2022$9,823,000
+58.1%
988,278
+87.2%
0.01%
+66.7%
Q4 2021$6,212,000
+139.8%
527,803
+132.0%
0.00%
+50.0%
Q3 2021$2,591,000
-58.5%
227,515
-49.2%
0.00%
-50.0%
Q2 2021$6,244,000
-30.1%
448,210
-7.1%
0.00%
-33.3%
Q1 2021$8,933,000
+101.9%
482,636
+92.8%
0.01%
+100.0%
Q4 2020$4,424,000
-18.2%
250,394
-29.1%
0.00%
-57.1%
Q3 2020$5,408,000
-4.5%
353,029
+58.8%
0.01%
-12.5%
Q2 2020$5,663,000
+103.6%
222,246
+23.7%
0.01%
+33.3%
Q1 2020$2,781,000
+20.1%
179,629
-14.2%
0.01%
+100.0%
Q4 2019$2,316,000
+312.8%
209,421
+574.0%
0.00%
+200.0%
Q1 2019$561,000
-81.2%
31,070
-70.8%
0.00%
-80.0%
Q4 2018$2,989,000
-47.2%
106,406
-52.1%
0.01%
-28.6%
Q3 2018$5,662,000
+1355.5%
222,050
+890.5%
0.01%
+600.0%
Q2 2018$389,00022,4190.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Spearhead Capital Advisors, LLC 202,580$2,601,0002.82%
Lion Point Capital, LP 480,000$5,140,0001.13%
HHLR ADVISORS, LTD. 2,920,023$37,493,0000.99%
TANG CAPITAL MANAGEMENT LLC 600,000$7,704,0000.94%
Rubric Capital Management LP 1,446,107$18,568,0000.94%
AlphaCentric Advisors LLC 43,000$552,0000.57%
RICE HALL JAMES & ASSOCIATES, LLC 749,933$9,629,0000.56%
Parkman Healthcare Partners LLC 126,192$1,620,0000.46%
Birchview Capital, LP 30,000$385,0000.27%
Baker Brothers Advisors 2,799,577$35,947,0000.24%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders